Naz Rahman
Stock Analyst at Maxim Group
(0.05)
# 4,762
Out of 5,044 analysts
470
Total ratings
34.4%
Success rate
-10.4%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Reiterated: Buy | $70 | $28.38 | +146.65% | 40 | Oct 7, 2026 | |
| SCNX Scienture Holdings | Reiterated: Buy | $1.5 | $3.76 | -60.11% | 5 | Oct 5, 2026 | |
| ACOG Alpha Cognition | Reiterated: Buy | $12 | $8.98 | +33.63% | 4 | Oct 1, 2026 | |
| NXGL NEXGEL | Reiterated: Hold | n/a | $0.1729 | - | 35 | Sep 28, 2026 | |
| NVCT Nuvectis Pharma | Reiterated: Buy | $30 | $20.03 | +49.78% | 16 | Sep 25, 2026 | |
| AYTU Aytu BioPharma | Reiterated: Buy | $7 | $2.05 | +241.46% | 21 | Sep 24, 2026 | |
| EOCN Eocene | Reiterated: Hold | n/a | $3.36 | - | 1 | Sep 10, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $16 → $20 | $4.72 | +323.73% | 35 | Sep 3, 2026 | |
| XTNT Xtant Medical Holdings | Reiterated: Buy | $1.5 | $0.3208 | +367.58% | 4 | Aug 28, 2026 | |
| SLXN Silexion Therapeutics | Reiterated: Hold | n/a | $0.2628 | - | 25 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.87 | +416.80% | 34 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.24 | +222.58% | 28 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.89 | +63.60% | 28 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.11 | +170.27% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.49 | +436.91% | 32 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $575 | $502.31 | +14.47% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 → €12.00 | €2.10 | +471.43% | 7 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $9.26 | +223.97% | 14 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.52 | - | 15 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.07 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.00355 | n/a | 11 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.8802 | n/a | 21 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0001 | n/a | 11 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.85 | n/a | 6 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.17 | n/a | 3 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $10.18 | n/a | 1 | Aug 12, 2021 |
Viking Therapeutics
Oct 7, 2026
Reiterated: Buy
Price Target: $70
Current: $28.38
Upside: +146.65%
Scienture Holdings
Oct 5, 2026
Reiterated: Buy
Price Target: $1.5
Current: $3.76
Upside: -60.11%
Alpha Cognition
Oct 1, 2026
Reiterated: Buy
Price Target: $12
Current: $8.98
Upside: +33.63%
NEXGEL
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.1729
Upside: -
Nuvectis Pharma
Sep 25, 2026
Reiterated: Buy
Price Target: $30
Current: $20.03
Upside: +49.78%
Aytu BioPharma
Sep 24, 2026
Reiterated: Buy
Price Target: $7
Current: $2.05
Upside: +241.46%
Eocene
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.36
Upside: -
Quoin Pharmaceuticals
Sep 3, 2026
Reiterated: Buy
Price Target: $16 → $20
Current: $4.72
Upside: +323.73%
Xtant Medical Holdings
Aug 28, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.3208
Upside: +367.58%
Silexion Therapeutics
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2628
Upside: -
Aug 18, 2026
Reiterated: Buy
Price Target: $20
Current: $3.87
Upside: +416.80%
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $1.24
Upside: +222.58%
Aug 14, 2026
Reiterated: Buy
Price Target: $8
Current: $4.89
Upside: +63.60%
Aug 13, 2026
Reiterated: Buy
Price Target: $3
Current: $1.11
Upside: +170.27%
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $1.49
Upside: +436.91%
Aug 5, 2026
Reiterated: Buy
Price Target: $575
Current: $502.31
Upside: +14.47%
Jul 27, 2026
Reiterated: Buy
Price Target: €16.00 → €12.00
Current: €2.10
Upside: +471.43%
Jul 15, 2026
Reiterated: Buy
Price Target: $30
Current: $9.26
Upside: +223.97%
Nov 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.52
Upside: -
Aug 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.07
Upside: n/a
Dec 18, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.00355
Upside: n/a
Nov 20, 2024
Reiterated: Hold
Price Target: n/a
Current: $0.8802
Upside: n/a
May 17, 2023
Reiterated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Reiterated: Hold
Price Target: n/a
Current: $4.85
Upside: n/a
Jan 13, 2022
Reiterated: Hold
Price Target: n/a
Current: $4.17
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $6
Current: $10.18
Upside: n/a